S&P 500

5.469,30

0,39%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Galapagos NV (PK) (GLPGF)
Galapagos NV (PK) (GLPGF) Notícias

GLPGF

Galapagos NV (PK) (GLPGF)

Galapagos NV (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:GLPGF

1

Data	Hora	Fonte	Título	Código	Companhia
17/06/2024	08:38	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GLPGF	Galapagos NV (PK)
04/12/2023	19:16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	USOTC:GLPGF	Galapagos NV (PK)
15/06/2023	18:03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:GLPGF	Galapagos NV (PK)
07/06/2023	17:46	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:GLPGF	Galapagos NV (PK)
14/02/2023	15:51	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:GLPGF	Galapagos NV (PK)
02/11/2021	17:45	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:GLPGF	Galapagos NV (PK)
26/10/2021	17:08	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:GLPGF	Galapagos NV (PK)
10/05/2021	13:52	Edgar (US Regulatory)	Schedule 13g	USOTC:GLPGF	Galapagos NV (PK)
25/03/2021	20:11	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:GLPGF	Galapagos NV (PK)
25/09/2020	07:05	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GLPGF	Galapagos NV (PK)
12/11/2013	04:49	GlobeNewswire Inc.	Galapagos subsidiary BioFocus signs agreement with Biogen Idec in scleroderma	USOTC:GLPGF	Galapagos NV (PK)
21/10/2013	14:13	GlobeNewswire Inc.	Galapagos increases share capital through warrant exercises	USOTC:GLPGF	Galapagos NV (PK)
17/10/2013	02:33	GlobeNewswire Inc.	Galapagos presents superior potentiator series for CF	USOTC:GLPGF	Galapagos NV (PK)
16/10/2013	02:44	GlobeNewswire Inc.	Galapagos to present Phase 1 data on FFA2 antagonist GLPG0974 at UEG Week in Berlin	USOTC:GLPGF	Galapagos NV (PK)
16/10/2013	02:34	GlobeNewswire Inc.	Galapagos to present GLPG0634 at ACR	USOTC:GLPGF	Galapagos NV (PK)
30/09/2013	13:46	GlobeNewswire Inc.	Delta Lloyd notify of 9.93% shareholding in Galapagos	USOTC:GLPGF	Galapagos NV (PK)
24/09/2013	09:09	GlobeNewswire Inc.	AbbVie and Galapagos to co-develop cystic fibrosis therapies	USOTC:GLPGF	Galapagos NV (PK)
18/09/2013	13:07	GlobeNewswire Inc.	Galapagos creates new warrant plan	USOTC:GLPGF	Galapagos NV (PK)